Articles From: Shire Buys Back 88,200 Shares for Treasury to Shoppers Drug Mart Corporation Reports Strong Fourth Quarter Results


2013/4/18
LONDON --
Sign-up for Shire Buys Back 88,200 Shares for Treasury investment picks
2013/4/11
LONDON --
Sign-up for Shire Buys Back 91,900 Shares investment picks
2013/2/14
DUBLIN, Ireland , February 14, 2013 /PRNewswire/ --   1.
Sign-up for Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013 investment picks
2013/4/9
New findings reveal the substantial burden of rare diseases due to lack of resources, financial challenges and emotional unrest LEXINGTON, Mass.
Sign-up for Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases investment picks
2013/4/16
LONDON --
Sign-up for Shire PLC Buys 122,500 Own Shares to Hold in Treasury investment picks
2013/5/9
LONDON --Drug company Shire PLC (SHP.LN) said Thursday that it has prevailed in its litigation against Watson companies that are now part of Actavis Inc. (ACT) over their Abbreviated New Drug Application for a generic version of Shire's LIALDA delayed release tablets, a colitis treatment.
Sign-up for Shire Prevails in Litigation over LIALDA Colitis Treatment investment picks
2013/2/1
PHILADELPHIA , February 1, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached an agreement in principle to resolve the previously disclosed civil investigation into Shire's U.S. sales and marketing practices relating to ADDERALL XR ® , VYVANSE ® and DAYTRANA ®[1] .
Sign-up for Shire Reaches Agreement in Principle With U.S. Government investment picks
2013/2/13
The month-long "The Diabetic You" mobile bus tour will visit five Arizona and California communities SAN DIEGO , Feb.
Sign-up for Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications investment picks
2013/4/25
PHILADELPHIA , April 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary, Shire LLC, has settled all pending litigation with Actavis, Inc., Actavis LLC, and Actavis Elizabeth LLC (collectively "Actavis") and Watson Laboratories, Inc.- Florida , Watson Pharma, Inc. and ANDA, Inc. (collectively " Watson ") in connection with Actavis' and Watson's Abbreviated New Drug Applications ("ANDAs") for generic versions of Shire's INTUNIV ® ( guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.
Sign-up for Shire Settles All Pending Litigation with Actavis and Watson Concerning INTUNIV® investment picks
2013/4/25
LONDON --Drug group Shire PLC (SHP.LN) said Thursday that it has settled all pending litigation with Actavis Inc and Watson Laboratories Inc in connection with Actavis' and Watson's Abbreviated New Drug Applications for generic versions of Shire's hyperactivity treatment INTUNIV.
Sign-up for Shire Settles with Actavis and Watson over Generic Versions of INTUNIV investment picks
2013/2/28
LEXINGTON, Massachusetts , February 28, 2013 /PRNewswire/ -- - Global Initiatives Underscore Company's Long-Term Commitment to the Rare Disease Community Shire plc (LSE: SHP, NASDAQ: SHPG) today announced its support of Rare Disease Day, joining patients, healthcare providers, and patient organizations around the world to support a day that focuses attention on rare diseases as a public health issue, and highlights the need for more understanding and awareness about these diseases.
Sign-up for Shire Supports Rare Disease Day 2013 investment picks
2013/3/25
Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease LEXINGTON, Massachusetts , March 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California .
Sign-up for Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology investment picks
2013/5/17
PHILADELPHIA , May 17, 2013 /PRNewswire/ -- Research explores data on treatments for psychiatric disorders; health economics and outcomes research also   to   be presented Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association (APA) 166th Annual Meeting in San Francisco , May 18-22 .
Sign-up for Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting investment picks
2013/5/9
PHILADELPHIA , May 9, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary, Shire Development LLC, has prevailed in its litigation against Watson Pharmaceuticals Inc., Watson Laboratories, Inc.- Florida , Watson Pharma, Inc. and Watson Laboratories, Inc. (collectively " Watson ", now "Actavis") in connection with their Abbreviated New Drug Application ("ANDA") for a generic version of Shire's LIALDA ® (mesalamine) delayed release tablets for the induction of remission in adults with active, mild to moderate ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Sign-up for Shire Wins Patent Trial Against Watson Concerning LIALDA® investment picks
2013/2/19
LEXINGTON, Massachusetts , February 19, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that the Lysosomal Disease Network (LDN) presented Shire Human Genetic Therapies (HGT) with the first ever Novel Treatment Award for VPRIV on February 14 th , at its 9th Annual WORLD Symposium.
Sign-up for Shire's VPRIV® Wins First Ever "Novel Treatment Award" From Lysosomal Disease Network at Their 9th WORLD Symposium investment picks
2013/5/1
8 th Annual Client Conference Features Best-Selling Author Bonnie St.
Sign-up for SHL LINK Conference Brings Together Experts and Global Corporations to Explore Innovative Talent Management Strategies to Maximize Workforce Impact investment picks
2013/3/6
Shoe Carnival, Inc. (NASDAQ: SCVL) , a leading retailer of value-priced footwear and accessories, today reported unaudited sales results and updated earnings expectations for the fourth quarter and fiscal year ended February 2, 2013.
Sign-up for Shoe Carnival Announces Fourth Quarter and Full Year 2012 Unaudited Sales and Earnings investment picks
2013/3/28
Shoe Carnival, Inc. (NASDAQ:SCVL) a leading retailer of value-priced footwear and accessories, announced today that its Board of Directors has approved the payment of a quarterly cash dividend.
Sign-up for Shoe Carnival Declares Quarterly Cash Dividend investment picks
2013/4/1
Shoe Carnival, Inc. (NASDAQ: SCVL) a leading retailer of value-priced footwear and accessories, today announced net sales and earnings for the fourth quarter and fiscal year ended February 2, 2013.
Sign-up for Shoe Carnival Reports Fourth Quarter and Record Full Year 2012 Results investment picks
2013/5/15
Shoe Carnival, Inc. (Nasdaq: SCVL) a leading retailer of value-priced footwear and accessories, today announced first quarter 2013 earnings results will be released on Thursday, May 23, 2013 after the market close.
Sign-up for Shoe Carnival to Report First Quarter 2013 Financial Results on May 23, 2013 investment picks
2013/2/27
Shoe Carnival, Inc. (Nasdaq: SCVL) , a leading retailer of value-priced footwear and accessories, today announced fourth quarter and fiscal year 2012 earnings results will be released on Monday, April 1, 2013 after the market close.
Sign-up for Shoe Carnival to Report Fourth Quarter and Fiscal Year 2012 Financial Results on April 1, 2013 investment picks
2013/2/21
Shop for Healthier Foods at Loblaws® Canada NewsWire Eating healthier is made easy with a variety of New! and Must Try! President's Choice® foods BRAMPTON, ON, Feb.
Sign-up for Shop for Healthier Foods at Loblaws® investment picks
2013/4/23
This month, Keds ® new apparel line is launching at 150 Macy’s stores nationwide and online at macys.com and Keds.com. The collection of sportswear separates is inspired by the brand’s all-American heritage, featuring classically tailored staples that coordinate seamlessly with the Keds footwear line.
Sign-up for Shop Keds® New Apparel Line at Macy’s and Macys.com This April investment picks
2013/2/12
Virtual Piggy, Inc. (OTCBB: VPIG) , an innovator in safe youth payments, today announced that it has added its youth-friendly payment system to Ty’s ecommerce website.
Sign-up for Shop With Award-Winning Virtual Piggy at Ty.Com investment picks
2013/2/26
E-tailer Reports 35% More Page Views And Nearly Double Online Sales PALM SPRINGS, Calif.
Sign-up for ShopJimmy Turns To Akamai For Improved Site Performance investment picks
2013/2/28
Shoppers Drug Mart Corporation Files 2012 Audited Financial Statements and Management's Discussion and Analysis on Sedar Canada NewsWire The Company also wishes to notify shareholders that its 2012 Annual Report, Notice of Annual Meeting of Shareholders, Management Proxy Circular and related materials will be mailed to them by no later than April 3, 2013 .
Sign-up for Shoppers Drug Mart Corporation Files 2012 Audited Financial Statements and Management's Discussion and Analysis on Sedar investment picks
2013/5/15
Shoppers Drug Mart Corporation prices issuance of an aggregate of $500 million principal amount of Series 5 and Series 6 medium term notes Canada NewsWire /NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/ TORONTO , May 15, 2013 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC) today announced that it has priced the issuance of $225 million aggregate principal amount of 2.01% unsecured medium term notes, Series 5, due May 24, 2016 for aggregate net proceeds of $224,392,500 , as well as the issuance of $275 million aggregate principal amount of 2.36% unsecured medium term notes, Series 6, due May 24, 2018 for aggregate net proceeds of $273,933,000 .
Sign-up for Shoppers Drug Mart Corporation prices issuance of an aggregate of $500 million principal amount of Series 5 and Series 6 medium term notes investment picks
2013/2/13
Shoppers Drug Mart Corporation receives TSX approval to renew normal course issuer bid Canada NewsWire Purchases will be made by the Company in accordance with the requirements of the TSX and the price which the Company will pay for any such common shares will be the market price of any such common shares at the time of acquisition, or such other price as may be permitted by the TSX.
Sign-up for Shoppers Drug Mart Corporation receives TSX approval to renew normal course issuer bid investment picks
2013/4/25
Shoppers Drug Mart Corporation reports first quarter results Canada NewsWire Continued strength in front store sales and prescription count growth TORONTO , April 25, 2013 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC) today announced its financial results for the first quarter ended March 23, 2013 .
Sign-up for Shoppers Drug Mart Corporation reports first quarter results investment picks
2013/2/7
Shoppers Drug Mart Corporation Reports Strong Fourth Quarter Results Canada NewsWire -       ANNUAL DIVIDEND INCREASED BY 7.5% TO $1.14 PER SHARE -       RENEWAL OF SHARE REPURCHASE PROGRAM TORONTO , Feb.
Sign-up for Shoppers Drug Mart Corporation Reports Strong Fourth Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Shire Buys Back 88,200 Shares for Treasury to Shoppers Drug Mart Corporation Reports Strong Fourth Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity